Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
Based on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively....
Main Authors: | V. B. Mychka, I. E. Chazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2008-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1634 |
Similar Items
-
Nifedipine: 30 years of clinical experience
by: S. Yu. Martsevich
Published: (2005-04-01) -
Calcium antagonists: from history of creation to modern clinical practice
by: A. N. Kuchmin, et al.
Published: (2015-12-01) -
DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
by: S. Y. Martsevich
Published: (2015-12-01) -
Calcium antagonists in patients with high cardiovascular risk
by: A. A. Garganeeva
Published: (2009-08-01) -
New, long-acting form of nifedipine: efficacy and safety in patients with mild to moderate arterial hypertension
by: E. V. Alimova, et al.
Published: (2004-08-01)